Thank you for sharing!

Your article was successfully shared with the contacts you provided.

Flush from its victory earlier this year before the U.S. Supreme Court, the Federal Trade Commission has asked to submit an amicus curiae brief in a New Jersey federal case involving a drug patent settlement that delayed generic competition.

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2017 ALM Media Properties, LLC. All Rights Reserved.